Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays. - Wikidata - wikimedia - TriplyDB

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.

http://www.wikidata.org/entity/Q37363392

about

Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders.High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders.

P2860

Q40043990-77DA9463-7ABD-4867-81A9-D6B57B00D8E0 Q40116201-BA8E90A1-52E6-4323-9190-48E43E6500EC Q47580645-7E90E2E9-F34F-43BE-8A7E-CE50E6E19E3A

P2860

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays.

http://www.wikidata.org/entity/Q37363392

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Differential Detection of Huma ...... sia by Four Commercial Assays.

@en

Differential Detection of Huma ...... sia by Four Commercial Assays.

@nl

type

label

Differential Detection of Huma ...... sia by Four Commercial Assays.

@en

Differential Detection of Huma ...... sia by Four Commercial Assays.

@nl

prefLabel

Differential Detection of Huma ...... sia by Four Commercial Assays.

@en

Differential Detection of Huma ...... sia by Four Commercial Assays.

@nl

P1433

Q37363392-B3067500-4D4C-4D81-BAFF-E640B0EC11B0

P1476

Q37363392-1F53D4F5-CEE8-4054-BB52-C848EBA2FC66

P2093

Q37363392-15597CAB-0638-4496-B47D-26E2BB7FED9B

Q37363392-C33DF3DE-C8A5-4AC1-85DA-FE2048A13D2A

Q37363392-F5FAD732-138F-455E-84E1-BC6CFB25A72E

P2860

Q37363392-0948B293-9292-4212-A990-BA31A3D35992

Q37363392-13A24CFB-D597-4432-BF51-1D81C186EADC

Q37363392-2B44C256-A7D5-48CF-8946-CC01893D4C94

Q37363392-3250AAC0-D3C6-4BDC-823B-337B620425C3

Q37363392-3C8120CA-6E07-4A92-A4AC-A3AC7301F154

Q37363392-414C56B1-FCDE-4533-88AF-F76EB2208001

Q37363392-487F4D20-4913-487F-A2C9-0CBFCEE4073E

Q37363392-5A00C3CB-BBF5-4698-996A-111E2B08C702

Q37363392-5B71DD31-76F6-4924-8375-251B9FAD23B4

Q37363392-5BAEED8E-B9A1-41C5-8D25-F836976DDEB9

P304

Q37363392-79946419-CDBA-40AC-B72E-6F3AEA633712

P31

Q37363392-935146A9-B6EB-4B45-B7A3-0F9AC5DEF64A

P356

Q37363392-225F37CB-B25C-40CA-8B7D-B4FCE7C444DF

P407

Q37363392-4A697F25-0197-4227-9340-EF29DEDEFC9E

P433

Q37363392-934C00C9-FFC6-4155-ABF2-6DD6E3970A72

P478

Q37363392-474112AF-B25F-49C6-8723-773DB7779E45

P50

Q37363392-5BF707A4-9AF3-43C5-93D5-D85FBD4BBADE

Q37363392-B05A065F-B00A-46A3-A7AF-9757C347F20E

Q37363392-E614F9B2-7CB8-45A4-BEFD-89704B586100

Q37363392-F56DFBA3-D747-491A-827F-C46FAC047A26

P577

Q37363392-D69FEDB3-FE46-4943-ACC6-2327220DBD4B

P698

Q37363392-7D8192AA-053F-4DF1-B744-25571BBDBC26

P932

Q37363392-012D5AA9-DB47-4627-A867-FF68467F01A0

P356

P1433

Journal of Clinical Microbiology

P1476

Differential Detection of Huma ...... sia by Four Commercial Assays.

@en

P2093

Carsten Rygaard

http://www.w3.org/2001/XMLSchema#string

Ditte Ejegod

http://www.w3.org/2001/XMLSchema#string

Sarah Preisler

http://www.w3.org/2001/XMLSchema#string

P2860

A review of human carcinogens--Part B: biological agents

Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system.

Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening.

HPV testing by cobas HPV test in a population from Catalonia.

Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.

Clinical validation of the cobas 4800 HPV test for cervical screening purposes.

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.

P304

2669-2675

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.01321-16

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27535689

http://www.w3.org/2001/XMLSchema#string

P932

5078541

http://www.w3.org/2001/XMLSchema#string